You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intravitreal anti-VEGF (vascular endothelial growth factor)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Diabetic Macular Edema and Suboptimal Response to

Not yet recruiting
  • Diabetic Macular Edema
    • (no location specified)
    Jul 31, 2023

    Intravitreal Injection Site and Perceived Pain

    Recruiting
    • Pain
    • Intravitreal injection site
    • Galveston, Texas
      University of Texas Medical Branch
    Jan 19, 2023

    Age Related Macular Degeneration Trial in Xuzhou (recombinant anti-vascular endothelial growth factor (VEGF) humanized mAb

    Recruiting
    • Age Related Macular Degeneration
    • recombinant anti-vascular endothelial growth factor (VEGF) humanized monoclonal antibody ophthalmic injection
    • Xuzhou, Jiangsu, China
      XuZhou Central Hospital
    Feb 7, 2022

    Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)

    Recruiting
    • Macular Edema Due to Type 2 Diabetes Mellitus
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Feb 26, 2023

    Exudative Age-related Macular Degeneration Trial (intravitreal injection)

    Completed
    • Exudative Age-related Macular Degeneration
    • intravitreal injection
    • (no location specified)
    Apr 19, 2022

    Following Intensive Anti-VEGF Therapy in Wet AMD

    Completed
    • Age-Related Macular Degeneration
    • Budapest, Hungary
    • +1 more
    Dec 28, 2022

    Retinal Vein Occlusion Trial in Winston-Salem (Aflibercept Ophthalmic)

    Recruiting
    • Retinal Vein Occlusion
    • Aflibercept Ophthalmic
    • Winston-Salem, North Carolina
      Wake Forest Health Sciences
    Jan 5, 2022

    Uveitis, Macular Edema, Vascular Endothelial Growth Factor Trial in Beijing (intravitreal injection of Conbercept)

    Terminated
    • Uveitis
    • +3 more
    • intravitreal injection of Conbercept
    • Beijing, Beijing, China
      Peking Union Medical College Hospital (PUMCH)
    Oct 24, 2022

    Macular Disease Trial in Omaha

    Suspended
    • Macular Disease
      • Omaha, Nebraska
      • +1 more
      Sep 16, 2022

      Anti-VEGF in Real-world

      Recruiting
      • Neovascular Age-related Macular Edema
      • +5 more
      • Beijing, Beijing, China
        Wen-Bin Wei
      Feb 2, 2022

      Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular

      Completed
      • AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
      • Wenzhou, Zhejiang, China
        The First Affiliated Hospital of Wenzhou Medical University
      Nov 6, 2023

      Exudative Age Related Macular Degeneration Trial in Winston-Salem (Ranibizumab, Photodynamic laser treatment (PDT),

      Not yet recruiting
      • Exudative Age Related Macular Degeneration
      • Winston-Salem, North Carolina
        Wake Forest Health Sciences
      Nov 28, 2022

      Iris Trial in Assiut (Immunohistochemistry analysis)

      Not yet recruiting
      • Iris
      • Immunohistochemistry analysis
      • Assiut, Egypt
        Hassan Lotfy
      Jul 29, 2022

      Ocular Adverse Events in Neovascular Age-related Macular

      Completed
      • Age-related Macular Degeneration (AMD)
      • Aflibercept
      • +2 more
      • East Hanover, New Jersey
        Novartis Investigative Site
      Dec 15, 2021

      Uveitis, Cystoid Macular Edema Trial in Winston-Salem (Pegaptanib)

      Completed
      Has Results
      • Uveitis
      • Cystoid Macular Edema
      • Winston-Salem, North Carolina
        Wake Forest University Eye Center
      Mar 7, 2022

      Diabetic Macular Edema, Cataract Trial in Walnut Creek (Bevacizumab, Ranibizumab, Aflibercept)

      Recruiting
      • Diabetic Macular Edema
      • Cataract
      • Walnut Creek, California
        Bay Area Retina Associates
      Mar 1, 2022

      Refractory Angina Pectoris, Gene Transfer, Coronary Artery Disease Trial in Copenhagen, Kuopio (AdvVEGF-D, Control Rx)

      Recruiting
      • Refractory Angina Pectoris
      • +2 more
      • Copenhagen, Denmark
      • +1 more
      Oct 19, 2022

      Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy Trial in Cairo (Intravitreal ranibizumab, Intravitreal

      Recruiting
      • Diabetic Macular Edema
      • +3 more
      • Intravitreal ranibizumab
      • Intravitreal bevacizumab
      • Cairo, Egypt
        Cairo University
      Nov 26, 2021

      Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

      Active, not recruiting
      • Diarrhea
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jun 7, 2022

      Neovascular Age-related Macular Degeneration, Wet Macular Degeneration Trial in United States (Dorzolamide-timolol, Artificial

      Completed
      Has Results
      • Neovascular Age-related Macular Degeneration
      • Wet Macular Degeneration
      • Palo Alto, California
      • +4 more
      Jun 5, 2020

      Neovascular Age-related Macular Degeneration(nAMD) Trial in Shanghai, Tianjin (HG202)

      Not yet recruiting
      • Neovascular Age-related Macular Degeneration(nAMD)
      • HG202
      • Shanghai, Shanghai, China
      • +1 more
      Sep 4, 2023

      Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial

      Recruiting
      • Diabetic Macular Edema
      • +4 more
      • Anti-vascular endothelial growth factors (Anti-VEGFs)
      • Banhā, Benha, Egypt
        Ahmed Abdelshafy Tabl
      Aug 8, 2022

      Recurrent Brain Tumor Trial in Houston (biological, other, radiation)

      Active, not recruiting
      • Recurrent Brain Neoplasm
      • Bevacizumab
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      Neovascular Age-related Macular Degeneration (nAMD) Trial (AR-14034 SR implant lower dose, Aflibercept Injection, Sham

      Not yet recruiting
      • Neovascular Age-related Macular Degeneration (nAMD)
      • AR-14034 SR implant lower dose
      • +3 more
      • (no location specified)
      Mar 3, 2023

      Focal Laser Single Intravitreal Ranibizumab Retinal Artery

      Completed
      • Retinal Artery Macroaneurysm
      • Dual focal laser and intravitreal Ranibizumab injection
      • Cairo, Egypt
        Kasr alainy faculty of medicine
      Jan 29, 2023